The involvement of the RET variant G691S in medullary thyroid carcinoma: Conflicting results of meta-analyses need to be reconciled

International Journal of Cancer

Volumn 133, Issue 7, 2013, Pages 1760-1761

  Lantieri, Francesca ^a   Caroli, Francesco ^b   Ceccherini, Isabella ^b   Griseri, Paola ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

CANCER SUSCEPTIBILITY; CARCINOGENESIS; EXON; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECESSIVE INHERITANCE; RET GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID MEDULLARY CARCINOMA;

HUMANS; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 84880296637     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28177     Document Type: Letter

References (10)

1. Cebrian A, Lesueur F, Martin S, et al. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 2005; 90: 6268-74.
2. Elisei R, Cosci B, Romei C, et al. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. J Clin Endocrinol Metab 2004; 89: 3579-84.
3. Fugazzola L, Muzza M, Mian C, et al. RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series. Clin Endocrinol (Oxf) 2008; 69: 418-25.
4. Fernández RM, Peciña A, Antiñolo G, et al. Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma. Thyroid 2006; 16: 411-7.
5. Lantieri F, Caroli F, Ceccherini I, et al. The involvement of the RET variant G691S in medullary thyroid carcinoma enlightened by a meta-analysis study. Int J Cancer 2012 Nov 26; doi: 10.1002/ijc.27967.
6. Figlioli G, Landi S, Romei C, et al. Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. Mutat Res. 2013; 752: 36-44.
7. Bugalho MJ, Cote GJ, Khorana S, et al. Identification of a polymorphism in exon 11 of the RET protooncogene. Hum Mol Genet 1994; 3: 2263.
8. Robledo M, Gil L, Pollán M, et al. Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A. Cancer Res 2003; 63: 1814-7.
9. Wohllk GN, Soto CE, Bravo AM, et al. G691S, L769L and S836S ret proto-oncogene polymorphisms are not associated with higher risk to sporadic medullary thyroid carcinoma in Chilean patients. Rev Med Chil 2005; 133: 397-402.
10. Severskaia NV, Saenko VA, Il'in AA, et al. RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients. Mol Biol (Mosk) 2006; 40: 425-35.